#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10836	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2033	522.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	601	C	580	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10836	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2033	522.7	0	HET	.	.	.	A69G	.	69	69	A	303	303	A	591	A,G	431,142	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19704	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3568	548.0	0	.	n	.	0	T695C	SNP	695	695	T	1033	1033	C	602	C	587	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19704	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3568	548.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1675	1675	A	666	A,G	644,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19704	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3568	548.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2309	2309	C	619	C,G	600,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19704	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3568	548.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2383	2383	A	582	A	575	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19704	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3568	548.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2935	2935	C	577	C,A	566,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19704	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3568	548.0	0	HET	.	.	.	G694T,A	.	694	694	G	1032	1032	G	596	G,T,A	441,138,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	G5V	NONSYN	13	15	GGT	294	296	GTT	79;80;80	G;T;T	78;78;77	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	E12K	NONSYN	34	36	GAA	315	317	AAA	93;98;98	A,G;A;A	88,2;94;94	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	F31L	NONSYN	91	93	TTT	372	374	TTG	105;105;104	T;T;G,T	105;104;102,2	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	405	407	CAA	129;125;125	C;A;A	126;122;123	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	S75P	NONSYN	223	225	TCC	504	506	CCT	128;128;128	C;C;T	124;126;124	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	V87A	NONSYN	259	261	GTA	540	542	GCA	110;110;112	G;C;A,G	107;104;104,2	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	V130L	NONSYN	388	390	GTC	669	671	CTC	126;127;128	C,G;T;C	119,1;119;127	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	R135C	NONSYN	403	405	CGC	684	686	TGT	130;128;126	T,G;G;T	116,1;126;116	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	T137A	NONSYN	409	411	ACG	690	692	GCG	128;127;125	G;C,G;G	126;110,1;122	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	732	734	AAG	127;130;133	A;A;G	122;125;130	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	T152N	NONSYN	454	456	ACC	735	737	AAT	133;134;135	A;A;T	130;131;133	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	F218L	NONSYN	652	654	TTT	933	935	TTG	103;102;104	T;T;G	102;99;102	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	963	965	AGC	93;94;92	A;G;C	92;92;92	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1032	1034	CTG	72;69;68	C,T;T;G	69,1;62;66	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1038	1040	TCC	66;66;65	T,G;C;C,T	64,1;60;63,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1053	1055	GTG	79;79;83	G;T,C;G	76;67,1;81	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1146	folP	852	852	93.78	folP.l15.c4.ctg.1	1474	77.2	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1104	1106	GCG	105;103;104	G;C;G	100;97;98	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4236	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3280	127.6	1	SNP	p	S91F	1	.	.	271	273	TTC	571	573	TTC	164;163;163	T;T,C;C	162;157,2;158	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4236	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3280	127.6	1	SNP	p	D95G	1	.	.	283	285	GGC	583	585	GGC	160;155;157	G;G,A;C	154;150,2;154	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4236	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3280	127.6	1	SNP	p	G95N	0	.	.	283	285	GGC	583	585	GGC	160;155;157	G;G,A;C	154;150,2;154	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1226	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1232	97.8	1	SNP	p	G45D	0	.	.	133	135	GGC	409	411	GGC	144;144;146	G,A;G,A;C	141,1;137,2;143	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	678	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	962	69.7	0	.	n	.	0	A197.	DEL	197	197	A	556	556	A	143	A	140	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3630	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	123.7	1	SNP	p	D86N	0	.	.	256	258	GAC	569	571	GAC	129;127;128	G;A;C	126;121;127	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3630	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	123.7	1	SNP	p	R87I	0	.	.	259	261	CGT	572	574	CGT	130;131;130	C,A;G;T	128,1;131;130	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3630	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	123.7	1	SNP	p	R87W	0	.	.	259	261	CGT	572	574	CGT	130;131;130	C,A;G;T	128,1;131;130	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3630	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	123.7	1	SNP	p	S87R	1	.	.	259	261	CGT	572	574	CGT	130;131;130	C,A;G;T	128,1;131;130	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3630	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2901	123.7	1	SNP	p	S88P	0	.	.	262	264	TCC	575	577	TCC	130;128;127	T;C;C	129;128;127	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3204	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2742	115.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1557	1559	GGC	170;169;165	G;G;C	165;161;158	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1336	1338	GCA	150;153;153	G;C;A,C	145;149;147,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1339	1341	ATC	151;151;152	A;T;C,G	149;148;149,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1351	1353	GTG	148;148;149	G,A;T,C;G,C	143,1;140,1;143,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1351	1353	GTG	148;148;149	G,A;T,C;G,C	143,1;140,1;143,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1855	1857	ACC	137;137;136	A;C;C	131;131;134	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1909	1911	GCG	125;125;123	G;C,G;G	116;101,3;114	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1909	1911	GCG	125;125;123	G;C,G;G	116;101,3;114	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2032	2034	AGC	126;124;123	A,G;G;C,T	122,1;123;122,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2041	2043	GGC	120;121;118	G,A;G;C	118,1;119;115	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2702	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2462	108.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2059	2061	CCG	88;87;87	C,G;C;G	72,1;73;72	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4196	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3159	132.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1657	1659	CCG	138;139;136	C;C;G,C	128;134;128,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1872	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1835	100.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	610	610	C	122	C	117	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2000	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1519	130.2	0	.	p	.	0	G46S	NONSYN	136	138	GGC	464	466	AGC	152;152;150	A,G;G;C	147,3;152;149	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2000	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1519	130.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	959	959	T	131	T	122	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2000	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1519	130.2	1	SNP	p	G120K	0	.	.	358	360	GGT	686	688	GGT	140;137;137	G;G;T	136;134;130	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2000	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1519	130.2	1	SNP	p	A121D	0	.	.	361	363	GCC	689	691	GCC	136;133;133	G;C;C	134;132;131	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2000	porB1b	1035	1035	98.57	porB1b.l15.c30.ctg.1	1519	130.2	1	SNP	p	A121N	0	.	.	361	363	GCC	689	691	GCC	136;133;133	G;C;C	134;132;131	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6934	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4859	141.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	824	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1159	70.7	1	SNP	p	V57M	1	.	.	169	171	ATG	615	617	ATG	178;181;183	A;T;G	175;177;179	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
